Olema Pharmaceuticals (OLMA) Current Leases (2021 - 2026)
Olema Pharmaceuticals (OLMA) reported Current Leases of $956000.0 for Q1 2026, down 6.73% year-over-year from $1.0 million in Q1 2025, and down 14.95% quarter-over-quarter from $1.1 million in Q4 2025.
Olema Pharmaceuticals (OLMA) Current Leases (2021 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has 6 years of Current Leases data on file, last reported at $956000.0 in Q1 2026.
- Current Leases for Q1 2026 came in at $956000.0, down 6.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $956000.0 (down 6.73% YoY), and the FY2025 annual result was $1.1 million, down 4.1% from the prior year.
- Current Leases declined to $956000.0 in Q1 2026 per OLMA's latest filing, from $1.1 million in the prior quarter.
- Over five years, Current Leases peaked at $1.2 million in Q4 2024 and troughed at $798000.0 in Q2 2023.
- A 5-year average of $1.0 million and a median of $1.1 million in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2024: Current Leases declined 25.97% in 2023, then surged 38.22% in 2024.
- A 5-year view of Current Leases shows it stood at $1.0 million in 2022, then retreated by 2.66% to $988000.0 in 2023, then advanced by 18.62% to $1.2 million in 2024, then dropped by 4.1% to $1.1 million in 2025, then retreated by 14.95% to $956000.0 in 2026.
- Business Quant data shows OLMA's Current Leases at $956000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Olema Pharmaceuticals | 1.01 Bn | 1.01 Bn | - | 956,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 956,000.00 |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 1.06 Mn |
| Dec 31, 2023 | 988,000.00 |
| Sep 30, 2023 | 924,000.00 |
| Jun 30, 2023 | 798,000.00 |
| Mar 31, 2023 | 908,000.00 |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 1.08 Mn |
| Mar 31, 2022 | 881,000.00 |
| Dec 31, 2021 | 931,000.00 |